Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10806248 | 0.95 | KMT2A (0.56) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| SCHEMBL10407615 | 0.92 | HSP90AA1 (0.56) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| SCHEMBL10474603 | 0.84 | HSP90AA1 (0.46) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| SCHEMBL10513033 | 0.84 | CYP3A4 (0.51) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| SCHEMBL10551518 | 0.84 | HSP90AA1 (0.66) | KMT2AHSP90AA1CYP3A4ALDH1A1CYP19A1 | |
| SCHEMBL9661753 | 0.84 | HSP90AA1 (0.66) | KMT2AHSP90AA1CYP3A4ALDH1A1CYP19A1 | |
| SCHEMBL10554799 | 0.84 | HSP90AA1 (0.66) | KMT2AHSP90AA1CYP3A4ALDH1A1CYP19A1 | |
| SCHEMBL9719576 | 0.82 | KMT2A (0.68) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| SCHEMBL10794743 | 0.81 | HSP90AA1 (0.47) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 | |
| Water SCHEMBL11158440 | 0.81 | KMT2A (0.66) | KMT2AHSP90AA1CYP3A4ALDH1A1PDCD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0527851-B1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | SEARLE & CO (US) | 1998-12-23 | — | — | EP | disclosed |
| US-5674879-A | Compositions including and methods of using conformationally restricted angiotensin II antagonist | G.D. SEARLE & CO. (US) | 1997-10-07 | — | — | US | disclosed |
| US-5602153-A | Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a giaucoma disorder | G.D. SEARLE & CO. (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0508445-B1 | 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders | SEARLE & CO (US) | 1996-06-12 | — | — | EP | disclosed |
| EP-0619819-B1 | 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | SEARLE & CO (US) | 1996-06-12 | — | — | EP | disclosed |
| US-5426105-A | Cardiovascular disorders | G.D. SEARLE & CO. (US) | 1995-06-20 | — | — | US | disclosed |
| EP-0619819-A1 | 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. | SEARLE & CO (US) | 1994-10-19 | — | — | EP | disclosed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| WO-1992018092-A2 | 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-10-29 | — | — | WO | disclosed |
| EP-0508445-A1 | 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders | G.D. Searle & Co. (US) | 1992-10-14 | — | — | EP | disclosed |
| US-4945101-A | Fungicidal novel hydroxyalkynyl-azolyl derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1990-07-31 | — | — | US | disclosed |
| EP-0192055-B1 | HYDROXYALKYNYL-AZOLYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1989-08-09 | — | — | EP | disclosed |
| US-4731452-A | FUNGICIDE INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 1988-03-15 | — | — | US | disclosed |
| EP-0096786-B1 | HYDROXYALKYNYL-AZOLYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1987-09-16 | — | — | EP | disclosed |
| EP-0096801-B1 | AZOLYLMETHYL KETONES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS INTERMEDIATES | BAYER AG (DE) | 1987-09-09 | — | — | EP | disclosed |
| EP-0104549-B1 | AZOLYL BUTANOLES | BAYER AG (DE) | 1987-07-29 | — | — | EP | disclosed |
| EP-0192055-A2 | Hydroxyalkynyl-azolyl derivatives, process for their preparation and their use as fungicides | BAYER AG (DE) | 1986-08-27 | — | — | EP | disclosed |
| US-4578396-A | Fungicidal hydroxyalkinyl-azolyl derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1986-03-25 | — | — | US | disclosed |
| EP-0104549-A2 | Azolyl butanoles | BAYER AG (DE) | 1984-04-04 | — | — | EP | disclosed |
| EP-0096786-A2 | Hydroxyalkynyl-azolyl derivatives, process for their preparation and their use as fungicides | BAYER AG (DE) | 1983-12-28 | — | — | EP | disclosed |